Rectal cancer drug trial of dostarlimab cures all patients
[foxnews.com – 2022.06.10] The results of a small clinical trial have found that there could be a cure for rectal cancer. The trial — conducted by Memorial Sloan Kettering Cancer Center in Manhattan — involved at least 12 rectal cancer patients who took a drug called dostarlimab. That’s according to a paper published on Sunday […]
Rectal cancer drug trial of dostarlimab cures all patients Read More »